-
FDA approves Amneal generic for treatment of hypertension and liver cirrhosis
HAUPPAUGE, N.Y. The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis made by Amneal Pharmaceuticals, Amneal said Thursday.
The FDA approved Amneal’s spironolactone hydrochloride tablets in the 25 mg, 50 mg and 100 mg strengths. The drug is a generic version of Pfizer’s Aldactone. Various versions of the drug had sales of $91 million in 2009, according to IMS Health.
-
GlaxoSmithKline introduces ‘Nicorette Makes Quitting Suck Less’ ad campaign
PITTSBURGH To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise, GlaxoSmithKline earlier this week introduced a new commercial to its “Nicorette Makes Quitting Suck Less” campaign, the company announced Wednesday.
PITTSBURGH To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise, GlaxoSmithKline earlier this week introduced a new commercial to its “Nicorette Makes Quitting Suck Less” campaign, the company announced Wednesday.